Walędziak Maciej, Różańska-Walędziak Anna, Kowalewski Piotr K, Janik Michał R, Brągoszewski Jakub, Paśnik Krzysztof
Department of General, Oncological, Metabolic and Thoracic Surgery, Military Institute of Medicine, Warsaw, Poland.
2 Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland.
Wideochir Inne Tech Maloinwazyjne. 2017 Sep;12(3):325-329. doi: 10.5114/wiitm.2017.70215. Epub 2017 Sep 26.
Gastrointestinal stromal tumors (GISTs), originating from Cajal cells, are most commonly located in the stomach; therefore they can be found in the specimens excised during bariatric operations. The global prevalence of GISTs is about 130 cases per million population. Morbidity differs depending on geographical latitude. Although surgery is the treatment of choice for GISTs, 40-50% of patients after radical surgical treatment will have a relapse or metastases.
To analyze the incidence of GISTs in patients undergoing bariatric surgery and to verify whether an operation performed according to the bariatric protocol is oncologically radical in case of GIST.
A single-center retrospective study. The study group comprised 1252 obese patients qualified for bariatric procedures, with no upper gastrointestinal tract neoplasms found during preoperative diagnostic examinations. In case of suspicious macroscopic pathologies (n = 81) present during the operation, tissue specimens underwent histopathological examination with further investigation performed if GISTs were found, including tumor size and localization, mitotic index and immunohistochemical analysis.
Gastrointestinal stromal tumors were found in 16 cases, and benign tumors of various histological origin in 33 cases. All cases of GIST found came from stomach specimens, 7 from the gastric corpus vs. 9 from the fundus. Fourteen GISTs were found during laparoscopic sleeve gastrectomies (LSGs) vs. 2 during laparoscopic Roux-en-Y gastric bypasses (LRYGBs).
In case of incidental findings of GISTs during bariatric surgery, tumor resection with negative margins of incision may be considered as complete oncological treatment if there was very low/low risk stratification of GIST's recurrence after surgery.
胃肠道间质瘤(GIST)起源于 Cajal 细胞,最常见于胃部;因此,在减肥手术切除的标本中可能会发现它们。GIST 的全球患病率约为每百万人口 130 例。发病率因地理纬度而异。虽然手术是 GIST 的首选治疗方法,但根治性手术治疗后 40 - 50%的患者会复发或转移。
分析减肥手术患者中 GIST 的发病率,并验证在 GIST 病例中按照减肥手术方案进行的手术在肿瘤学上是否为根治性手术。
一项单中心回顾性研究。研究组包括 1252 名符合减肥手术条件的肥胖患者,术前诊断检查未发现上消化道肿瘤。如果手术中出现可疑的宏观病变(n = 81),组织标本进行组织病理学检查,若发现 GIST 则进一步检查,包括肿瘤大小和定位、有丝分裂指数和免疫组织化学分析。
发现 16 例胃肠道间质瘤,33 例为各种组织学来源的良性肿瘤。所有发现的 GIST 病例均来自胃标本,7 例来自胃体,9 例来自胃底。在腹腔镜袖状胃切除术(LSG)中发现 14 例 GIST,在腹腔镜 Roux - en - Y 胃旁路术(LRYGB)中发现 2 例。
在减肥手术中偶然发现 GIST 的情况下,如果手术后 GIST 复发的风险分层为极低/低风险,可考虑将切缘阴性的肿瘤切除术视为完整的肿瘤学治疗。